Bad Blood Quiz | One Week Quiz A

John Carreyrou
This set of Lesson Plans consists of approximately 114 pages of tests, essay questions, lessons, and other teaching materials.

Bad Blood Quiz | One Week Quiz A

John Carreyrou
This set of Lesson Plans consists of approximately 114 pages of tests, essay questions, lessons, and other teaching materials.
Buy the Bad Blood Lesson Plans
Name: _________________________ Period: ___________________

This quiz consists of 5 multiple choice and 5 short answer questions through Chapters 19 - 20.

Multiple Choice Questions

1. When did Lt. Col. Shoemaker make contact with the FDA directly by email regarding Theranos for the first time?
(a) January 3, 2010.
(b) June 14, 2012.
(c) December 9, 2011.
(d) September 2, 2009.

2. Where in Palo Alto was the building that Theranos moved to in early 2008?
(a) Waterman Avenue.
(b) Rockview Avenue.
(c) Kimble Avenue.
(d) Hillview Avenue.

3. For what German enterprise software juggernaut had Todd Surdey worked before coming to Theranos?
(a) Axel.
(b) IBM.
(c) SAP.
(d) Apple.

4. During the Serbian conflict of the 1990s, the Pentagon ensured it had the FDA's assent before offering troops a vaccine against what disease?
(a) SARS.
(b) Encephalitis.
(c) Ebola.
(d) H1N1.

5. For how much was Bebo acquired by AOL?
(a) $2.4 billion.
(b) $734 million.
(c) $45 million.
(d) $850 million.

Short Answer Questions

1. What number was Matt Bissel in terms of the first employees hired at Theranos?

2. How much money was Baxter demanded to pay in civil and criminal fines for the felony charge of violating the anti-boycott law in 1993?

3. Into what company's former headquarters had Theranose moved by 2012?

4. When did Elizabeth Holmes first meet with Jeremiah Kelly in regards to Theranos's use within the military?

5. In what field did Lt. Col. Shoemaker have a Ph.D.?

(see the answer key)

This section contains 196 words
(approx. 1 page at 300 words per page)
Buy the Bad Blood Lesson Plans
Copyrights
BookRags
Bad Blood from BookRags. (c)2026 BookRags, Inc. All rights reserved.